SAN FRANCISCO -- Earlier in the pandemic, experts had hoped if we can get 75% of Americans vaccinated, we can contain the coronavirus. Thursday, we're at just over 50% vaccinated. But 75% is no longer ...
SAN FRANCISCO (KGO) -- The Centers for Disease Control and Prevention (CDC) released new data Friday indicating the Delta variant is twice as infectious as previously thought, and a recent analysis ...
LOS ANGELES (KABC) -- Los Angeles County on Thursday reported its highest daily number of new COVID-19 infections since mid-May, and it is also seeing slight but noticeable increases in ...
Estimates show the variant accounts for over 51% of all new cases nationwide. A highly contagious variant of the novel coronavirus that was initially identified in India is now the dominant strain in ...
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...
Findings showed 100% of participants taking the tobevibart and elebsiran combination achieved an undetectable HDV RNA at week 24 that was sustained through week 60. The Food and Drug Administration ...
Vir Biotechnology (VIR) announced that tobevibart and elebsiran have received U.S. Food and Drug Administration Breakthrough Therapy designation and European Medicines Agency Priority Medicines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback